We show that NAbs are still detectable in most patients more than three months after mild COVID-19, with high levels of NAbs still detected after 200 days post infection which correlate strongly with results from commercial IgG-assays targeting both the N and the S-proteins. Here, PROS1 is linked to COVID-19.